Clarus Ventures

Latest statistics and disclosures from Clarus Ventures's latest quarterly 13F-HR filing:

  • Clarus Ventures was a net seller of stock by $0.

Companies in the Clarus Ventures portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Nanostring Technologies 52.08 3.96M 16.16
Sientra 34.23 2.73M 15.40
Vbi Vaccines 8.43 2.69M 3.85
Catabasis Pharmaceuticals 4.75 2.75M 2.12
Essa Pharma 0.50 2.12M 0.29

Past 13F-HR SEC Filings by Clarus Ventures

View All Filings